NM_002473.6:c.1083C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002473.6(MYH9):​c.1083C>T​(p.Asp361Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00448 in 1,614,138 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0045 ( 36 hom. )

Consequence

MYH9
NM_002473.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 2.54

Publications

4 publications found
Variant links:
Genes affected
MYH9 (HGNC:7579): (myosin heavy chain 9) This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011]
MYH9 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • May-Hegglin anomaly
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 22-36319565-G-A is Benign according to our data. Variant chr22-36319565-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 44548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.55 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00422 (642/152266) while in subpopulation AMR AF = 0.0116 (178/15292). AF 95% confidence interval is 0.0102. There are 3 homozygotes in GnomAd4. There are 309 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 642 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002473.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH9
NM_002473.6
MANE Select
c.1083C>Tp.Asp361Asp
synonymous
Exon 10 of 41NP_002464.1P35579-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH9
ENST00000216181.11
TSL:1 MANE Select
c.1083C>Tp.Asp361Asp
synonymous
Exon 10 of 41ENSP00000216181.6P35579-1
MYH9
ENST00000685801.1
c.1083C>Tp.Asp361Asp
synonymous
Exon 10 of 42ENSP00000510688.1A0A8I5KWT8
MYH9
ENST00000955568.1
c.1083C>Tp.Asp361Asp
synonymous
Exon 10 of 42ENSP00000625627.1

Frequencies

GnomAD3 genomes
AF:
0.00422
AC:
642
AN:
152148
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000918
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0117
Gnomad ASJ
AF:
0.0317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00412
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00464
AC:
1166
AN:
251438
AF XY:
0.00438
show subpopulations
Gnomad AFR exome
AF:
0.000923
Gnomad AMR exome
AF:
0.00928
Gnomad ASJ exome
AF:
0.0266
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.00443
Gnomad OTH exome
AF:
0.00505
GnomAD4 exome
AF:
0.00450
AC:
6585
AN:
1461872
Hom.:
36
Cov.:
32
AF XY:
0.00447
AC XY:
3250
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.000807
AC:
27
AN:
33478
American (AMR)
AF:
0.00912
AC:
408
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0267
AC:
697
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000730
AC:
39
AN:
53416
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00455
AC:
5065
AN:
1111998
Other (OTH)
AF:
0.00566
AC:
342
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
381
762
1143
1524
1905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00422
AC:
642
AN:
152266
Hom.:
3
Cov.:
32
AF XY:
0.00415
AC XY:
309
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000915
AC:
38
AN:
41536
American (AMR)
AF:
0.0116
AC:
178
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0317
AC:
110
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4808
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00412
AC:
280
AN:
68030
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00503
Hom.:
2
Bravo
AF:
0.00534
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00632
EpiControl
AF:
0.00522

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
4
not provided (4)
-
-
1
Atypical hemolytic-uremic syndrome (1)
-
-
1
Autosomal dominant nonsyndromic hearing loss 17 (1)
-
-
1
MYH9-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
13
DANN
Benign
0.86
PhyloP100
2.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56001030; hg19: chr22-36715610; COSMIC: COSV53384826; API